.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Argus Health
Harvard Business School
Federal Trade Commission
US Army
McKinsey
Covington
Cantor Fitzgerald
Daiichi Sankyo
Medtronic

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065192

« Back to Dashboard

NDA 065192 describes MUPIROCIN, which is a drug marketed by Glenmark Pharms Inc, Fougera Pharms, Glenmark Pharms, Perrigo New York, Taro, and Teva, and is included in six NDAs. It is available from twenty-seven suppliers. Additional details are available on the MUPIROCIN profile page.

The generic ingredient in MUPIROCIN is mupirocin. There are twelve drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the mupirocin profile page.

Summary for 065192

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 065192

Mechanism of ActionRNA Synthetase Inhibitors

Medical Subject Heading (MeSH) Categories for 065192

Suppliers and Packaging for NDA: 065192

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MUPIROCIN mupirocin OINTMENT;TOPICAL 065192 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0352 0168-0352-22 22 g in 1 TUBE (0168-0352-22)
MUPIROCIN mupirocin OINTMENT;TOPICAL 065192 ANDA Rebel Distributors Corp. 21695-188 21695-188-22 22 g in 1 TUBE (21695-188-22)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength2%
Approval Date:Nov 30, 2005TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Chubb
McKinsey
Colorcon
Johnson and Johnson
Federal Trade Commission
Express Scripts
QuintilesIMS
Mallinckrodt
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot